Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.

Rachel B Jones, Shunsuke Furuta, Jan Willem Cohen Tervaert, Thomas Hauser, Raashid Luqmani, Matthew D Morgan, Chen Au Peh, Caroline O Savage, Mårten Segelmark, Vladimir Tesar, Pieter van Paassen, Michael Walsh, Kerstin Westman, David Rw Jayne

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science